RELAY THERAPEUTICS INC's ticker is RLAY and the CUSIP is 75943R102. A total of 115 filers reported holding RELAY THERAPEUTICS INC in Q4 2020. The put-call ratio across all filers is - and the average weighting 1.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $75,438 | -11.8% | 8,970 | +31.7% | 0.00% | 0.0% |
| Q2 2023 | $85,546 | -23.7% | 6,811 | 0.0% | 0.00% | -25.0% |
| Q1 2023 | $112,177 | -20.7% | 6,811 | 0.0% | 0.00% | -33.3% |
| Q4 2022 | $141,533 | +9.7% | 6,811 | +17.5% | 0.01% | 0.0% |
| Q3 2022 | $129,000 | +33.0% | 5,798 | 0.0% | 0.01% | +50.0% |
| Q2 2022 | $97,000 | -40.1% | 5,798 | +7.2% | 0.00% | -33.3% |
| Q1 2022 | $162,000 | -2.4% | 5,408 | 0.0% | 0.01% | 0.0% |
| Q4 2021 | $166,000 | +14.5% | 5,408 | +17.8% | 0.01% | +20.0% |
| Q3 2021 | $145,000 | -13.7% | 4,590 | 0.0% | 0.01% | -16.7% |
| Q2 2021 | $168,000 | +30.2% | 4,590 | +23.1% | 0.01% | +20.0% |
| Q1 2021 | $129,000 | +13.2% | 3,730 | +36.0% | 0.01% | 0.0% |
| Q4 2020 | $114,000 | -2.6% | 2,743 | 0.0% | 0.01% | 0.0% |
| Q3 2020 | $117,000 | – | 2,743 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Casdin Capital, LLC | 6,923,574 | $58,227,257 | 6.44% |
| Finepoint Capital LP | 870,870 | $7,324,017 | 3.65% |
| Nextech Invest Ltd. | 1,196,409 | $10,061,800 | 3.05% |
| MPM BioImpact LLC | 1,352,133 | $11,371,439 | 3.04% |
| SB INVESTMENT ADVISERS (UK) LTD | 27,904,963 | $234,680,739 | 1.93% |
| EcoR1 Capital, LLC | 4,163,824 | $35,017,760 | 1.18% |
| Integral Health Asset Management, LLC | 800,000 | $6,728,000 | 0.93% |
| Alphabet Inc. | 1,568,753 | $13,193,212 | 0.85% |
| HARBOURVEST PARTNERS LLC | 296,402 | $2,492,741 | 0.85% |
| Boxer Capital, LLC | 1,819,132 | $15,298,900 | 0.81% |